Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura
H
H
Department of Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Tanabe
K
K
Tokumoto
T
T
Shimuzu
T
T
Ishikawa
N
N
Harano
M
M
Inui
M
M
Manu
M
M
Ito
S
S
Shimmura
H
H
Okuda
H
H
Yagisawa
T
T
Fuchinoue
S
S
Toma
H
H
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D012263:Ribonucleosides / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016896:Treatment Outcome
D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D001379:Azathioprine; C037258:gusperimus; D016559:Tacrolimus; D008775:Methylprednisolone